Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | caspase 1, apoptosis-related cysteine peptidase | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | caspase 8 | caspase 1, apoptosis-related cysteine peptidase | 383 aa | 312 aa | 26.6 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | hypothetical protein | 0.0082 | 0.2548 | 0.2548 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0082 | 0.2548 | 0.2548 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0177 | 0.6551 | 0.6551 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0082 | 0.2548 | 0.2602 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0119 | 0.4129 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0177 | 0.6551 | 0.6551 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0119 | 0.4129 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.005 | 0.1197 | 0.1197 |
Plasmodium vivax | metacaspase 1, putative | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0082 | 0.2548 | 0.2602 |
Schistosoma mansoni | hypothetical protein | 0.0082 | 0.2548 | 0.2602 |
Schistosoma mansoni | hypothetical protein | 0.0082 | 0.2548 | 0.2602 |
Echinococcus granulosus | caspase 2 | 0.0071 | 0.2098 | 0.2143 |
Schistosoma mansoni | hypothetical protein | 0.0177 | 0.6551 | 0.669 |
Brugia malayi | hypothetical protein | 0.005 | 0.1197 | 0.1197 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0082 | 0.2548 | 0.2548 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0119 | 0.4129 | 1 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0119 | 0.4129 | 0.4216 |
Echinococcus granulosus | raf serine:threonine protein kinase | 0.0254 | 0.9792 | 1 |
Plasmodium falciparum | metacaspase 1 | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0119 | 0.4129 | 1 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0254 | 0.9792 | 1 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0258 | 1 | 1 |
Brugia malayi | Raf kinase | 0.0245 | 0.9419 | 0.9419 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0082 | 0.2548 | 0.2602 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0258 | 1 | 1 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0119 | 0.4129 | 1 |
Echinococcus granulosus | apoptotic protease activating factor 1 | 0.005 | 0.1197 | 0.1223 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0119 | 0.4129 | 1 |
Plasmodium falciparum | metacaspase-like protein | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0258 | 1 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0119 | 0.4129 | 1 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0119 | 0.4129 | 1 |
Echinococcus multilocularis | caspase 2 | 0.0071 | 0.2098 | 0.2143 |
Brugia malayi | Cell death protein 3 precursor | 0.0071 | 0.2098 | 0.2098 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0119 | 0.4129 | 0.4216 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0082 | 0.2548 | 0.2602 |
Schistosoma mansoni | hypothetical protein | 0.0082 | 0.2548 | 0.2602 |
Plasmodium vivax | hypothetical protein, conserved | 0.0021 | 0 | 0.5 |
Loa Loa (eye worm) | raf kinase | 0.0252 | 0.974 | 0.974 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0119 | 0.4129 | 1 |
Brugia malayi | MAP kinase sur-1 | 0.0119 | 0.4129 | 0.4129 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0119 | 0.4129 | 1 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0119 | 0.4129 | 0.5 |
Echinococcus multilocularis | raf serine:threonine protein kinase | 0.0254 | 0.9792 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.2098 | 0.2098 |
Echinococcus granulosus | GPCR family 2 | 0.0082 | 0.2548 | 0.2602 |
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0119 | 0.4129 | 0.4216 |
Schistosoma mansoni | hypothetical protein | 0.005 | 0.1197 | 0.1223 |
Echinococcus multilocularis | apoptotic protease activating factor 1 | 0.005 | 0.1197 | 0.1223 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0119 | 0.4129 | 0.4216 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0119 | 0.4129 | 0.4216 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0082 | 0.2548 | 0.2602 |
Trypanosoma brucei | protein kinase, putative | 0.0119 | 0.4129 | 1 |
Schistosoma mansoni | caspase-7 (C14 family) | 0.0071 | 0.2098 | 0.2143 |
Loa Loa (eye worm) | TKL/RAF/RAF protein kinase | 0.0144 | 0.5161 | 0.5161 |
Echinococcus multilocularis | GPCR, family 2 | 0.0082 | 0.2548 | 0.2602 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0119 | 0.4129 | 1 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0119 | 0.4129 | 1 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0119 | 0.4129 | 0.4129 |
Onchocerca volvulus | Cell death protein 3 homolog | 0.0071 | 0.2098 | 1 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0082 | 0.2548 | 0.2548 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (functional) | = 7.7 uM | Inhibition of IL1beta production in PBMC | ChEMBL. | 16274992 |
EC50 (functional) | = 7.7 uM | Inhibition of IL1beta production in PBMC | ChEMBL. | 16274992 |
Ki (binding) | = 0.32 uM | Inhibitory activity against human Caspase 1 | ChEMBL. | 16274992 |
Ki (binding) | = 0.32 uM | Inhibitory activity against human Caspase 1 | ChEMBL. | 16274992 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 | 16274992 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.